Literature DB >> 20802211

Development and validation of a short version of the Stroke Specific Quality of Life Scale.

Marcel W M Post1, Hileen Boosman, Martine M van Zandvoort, Patricia E C A Passier, Gabriel J E Rinkel, Johanna M A Visser-Meily.   

Abstract

BACKGROUND AND
PURPOSE: The Stroke Specific Quality of Life Scale (SS-QoL) is a well validated measure of health related quality of life in patients with stroke, but with 49 items its length is a disadvantage. A short version of the SS-QoL was developed and tested here.
METHODS: Secondary analyses of three different studies. The short version was developed using data from 141 patients with aneurysmal subarachnoid haemorrhage (SAH) and tested on data from independent samples of 97 patients with SAH and 105 patients with ischaemic stroke or intracerebral haemorrhage. The item with the highest item domain correlation from each of the SS-QoL domains was selected to obtain a 12 item SS-QoL (SS-QoL-12) with a total score and physical and psychosocial subscores. Criterion validity of the SS-QoL-12 scores was tested in each sample with the original SS-QoL as reference.
RESULTS: All three scores of the SS-QoL-12 showed good internal consistency (Cronbach's alpha 0.77-0.89). The SS-Qol-12 scores predicted 88-95% of the variance of the original SS-QoL. Mean differences between the SS-QoL-12 and SS-QoL and their 95% CI were generally within 0.1 points on a 1-5 scale. The limits of agreement were generally within 0.4 points.
CONCLUSION: The SS-QoL-12 has good criterion validity for all subsets of stroke. Because it consists of only 12 questions, this short form will be easy to use in research and clinical settings.

Entities:  

Mesh:

Year:  2010        PMID: 20802211     DOI: 10.1136/jnnp.2009.196394

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group.

Authors:  Martin N Stienen; Johanna M Visser-Meily; Tom A Schweizer; Daniel Hänggi; R Loch Macdonald; Mervyn D I Vergouwen
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

2.  Validation of the 12-item stroke-specific quality of life scale in a biethnic stroke population.

Authors:  Kevin A Kerber; Devin L Brown; Lesli E Skolarus; Lewis B Morgenstern; Melinda A Smith; Nelda M Garcia; Lynda D Lisabeth
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-09-18       Impact factor: 2.136

3.  Ethnic Differences in Poststroke Quality of Life in the Brain Attack Surveillance in Corpus Christi (BASIC) Project.

Authors:  Sarah L Reeves; Devin L Brown; Jonggyu Baek; Jeffrey J Wing; Lewis B Morgenstern; Lynda D Lisabeth
Journal:  Stroke       Date:  2015-08-18       Impact factor: 7.914

4.  The effectiveness of an augmented cognitive behavioural intervention for post-stroke depression with or without anxiety (PSDA): the Restore4Stroke-PSDA trial.

Authors:  Joyce A Kootker; Luciano Fasotti; Sascha Mc Rasquin; Caroline M van Heugten; Alexander Ch Geurts
Journal:  BMC Neurol       Date:  2012-07-07       Impact factor: 2.474

5.  HRQOLISP-26: A Concise, Multiculturally Valid, Multidimensional, Flexible, and Reliable Stroke-Specific Measure.

Authors:  Mayowa Ojo Owolabi
Journal:  ISRN Neurol       Date:  2011-12-06

6.  Association of Neighborhood Socioeconomic Status With Outcomes in Patients Surviving Stroke.

Authors:  Eric L Stulberg; Erica Twardzik; Sehee Kim; Chia-Wei Hsu; Yuliang Xu; Philippa Clarke; Lewis B Morgenstern; Lynda D Lisabeth
Journal:  Neurology       Date:  2021-04-28       Impact factor: 11.800

7.  Stroke specific quality of life questionnaire: Test of reliability and validity of the Persian version.

Authors:  Mojtaba Mahmoodi; Anahid Safari; Mehrdad Vossoughi; Fatemeh Golbon-Haghighi; Maliheh Kamali-Sarvestani; Haleh Ghaem; Afshin Borhani-Haghighi
Journal:  Iran J Neurol       Date:  2015-04-04

8.  The effectiveness of problem solving therapy for stroke patients: study protocol for a pragmatic randomized controlled trial.

Authors:  Marieke M Visser; Majanka H Heijenbrok-Kal; Adriaan van 't Spijker; Gerard M Ribbers; Jan J V Busschbach
Journal:  BMC Neurol       Date:  2013-06-27       Impact factor: 2.474

9.  The Cognition and Affect after Stroke - a Prospective Evaluation of Risks (CASPER) study: rationale and design.

Authors:  Elles Douven; Syenna H J Schievink; Frans R J Verhey; Robert J van Oostenbrugge; Pauline Aalten; Julie Staals; Sebastian Köhler
Journal:  BMC Neurol       Date:  2016-05-12       Impact factor: 2.474

10.  The negative impact of spasticity on the health-related quality of life of stroke survivors: a longitudinal cohort study.

Authors:  Patrick J Gillard; Heidi Sucharew; Dawn Kleindorfer; Samir Belagaje; Sepideh Varon; Kathleen Alwell; Charles J Moomaw; Daniel Woo; Pooja Khatri; Matthew L Flaherty; Opeolu Adeoye; Simona Ferioli; Brett Kissela
Journal:  Health Qual Life Outcomes       Date:  2015-09-29       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.